3,083 reports of this reaction
3.4% of all ZOLEDRONIC ACID reports
#1 most reported adverse reaction
ARTHRALGIA is the #1 most commonly reported adverse reaction for ZOLEDRONIC ACID, manufactured by Sandoz Inc. There are 3,083 FDA adverse event reports linking ZOLEDRONIC ACID to ARTHRALGIA. This represents approximately 3.4% of all 89,511 adverse event reports for this drug.
ZOLEDRONIC ACID has an overall safety score of 88 out of 100. Patients taking ZOLEDRONIC ACID who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is moderately reported among ZOLEDRONIC ACID users, representing a notable but not dominant share of adverse events.
In addition to arthralgia, the following adverse reactions have been reported for ZOLEDRONIC ACID:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 3,083 FDA reports for ZOLEDRONIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 3.4% of all adverse event reports for ZOLEDRONIC ACID, making it one of the most commonly reported side effect.
If you experience arthralgia while taking ZOLEDRONIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.